Jaffetilchin Investment Partners’s Defiance Nasdaq Junior Biotechnology ETF IBBJ Stock Holding History

Jaffetilchin Investment Partners’s Portfolio IBBJ Stock Details IBBJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-8,631	Closed	-$252K	–	394
2021 Q3	$252K	Buy	+8,631	New	+$263K	0.03%	305

Jaffetilchin Investment Partners's IBBJ Position: Q4 2021 in Review

Jaffetilchin Investment Partners sold out of Defiance Nasdaq Junior Biotechnology ETF (IBBJ) in Q4 2021, closing a stake of 8,631 shares — an estimated $252K sold.

Jaffetilchin Investment Partners first reported a position in IBBJ in Q3 2021 and held it in 1 quarter. The position peaked at $252K in Q3 2021. 0 funds tracked by Wall St. Rank hold IBBJ as of Q4 2021.

Jaffetilchin Investment Partners reported no remaining Defiance Nasdaq Junior Biotechnology ETF position as of Q4 2021 after selling out during the quarter.
Jaffetilchin Investment Partners sold 8,631 Defiance Nasdaq Junior Biotechnology ETF shares in Q4 2021, an estimated $252K.
Jaffetilchin Investment Partners first reported a position in Defiance Nasdaq Junior Biotechnology ETF in Q3 2021 and held it in 1 quarter.
Jaffetilchin Investment Partners's Defiance Nasdaq Junior Biotechnology ETF position peaked at $252K in Q3 2021.
0 funds tracked by Wall St. Rank held Defiance Nasdaq Junior Biotechnology ETF as of Q4 2021.

Based on Jaffetilchin Investment Partners's 13F filing for Q4 2021, filed 17 Feb 2022.